Role of immunohistochemistry and flow cytometry in minimal residual disease detection in
NPM1
‐mutated AML
2016 ◽
pp. 217-225
2013 ◽
Vol 4
(3)
◽
pp. 189-198
◽
2016 ◽
Vol 72
(2)
◽
pp. 152-156
◽
1996 ◽
Vol 93
(1)
◽
pp. 251-252
◽
2018 ◽
Vol 40
(3)
◽
pp. 343-351
◽
2015 ◽
Vol 90
(1)
◽
pp. 47-53
◽
2019 ◽
Vol 19
(10)
◽
pp. e183-e184
2019 ◽
Vol 96
(4)
◽
pp. 310-318
◽